Biotech Bulls & Breakthroughs

About Biotech Bulls & Breakthroughs

Welcome to Biotech Bulls & Breakthroughs! This brand new podcast from BioPharmCatalyst explores the dynamic world of biotech investing alongside long-time biotech trader Sheff from Sheff Station. Each month, we will be discussing current events in the biotech industry and how these events impact investors, as well as a discussion of upcoming catalysts in the biotech space.

Publisher

BioPharmCatalyst

Category

business · news · science

Language

en

Explicit

No

First episode

1 May 2025

Latest episode

16 Oct 2026

Latest episodes

23 episodes in the feed.

1. 

   16 Oct 2026

   Biotech Stocks to Watch: FDA Shakeups, ESMO Data & Late 2026 Biotech Catalysts Sheff Is Watching

   The FDA is in flux, ESMO is approaching, and a series of clinical and regulatory catalysts could put biotech stocks in focus. John Gagliano and Sheff Sheffield mark their 20th episode together by reviewing developments and the companies on their radar. They discuss: 🔹 FDA leadership shakeup 🔹 ESMO in Madrid and the readouts 🔹 Catalysts to watch before year-end and early 2027. In this episode, you’ll hear about: Aldeyra Therapeutics (ALDX) and the potential relevance of the Outlook The...

2. 

   11 Sept 2026

   Biotech Stocks to Watch: The September – December Catalysts Sheff Is Watching

   In this episode, John Gagliano and Sheff Sheffield discuss the biggest biotech catalysts heading into the final months of 2026. They examine continued big-pharma acquisition activity, Novo Nordisk’s pediatric obesity data, GLP-1 expansion, and the importance of pinpointing dates for clinical readouts, regulatory decisions, and conference presentations. You'll discover: 🔹 Why big pharma M&A could continue supporting small- and mid-cap biotech stocks 🔹 How GLP-1 developments and pedi...

3. 

   26 Aug 2026

   Lithium, brain imaging, & the future of Alzheimer’s treatment with Alzamend CEO Stephan Jackman ALZN

   In this episode features John Gagliano in conversation with Stephan Jackman, CEO and director of Alzamend, about the company’s mission, “Making Alzheimer’s just a memory,” and its pipeline in Alzheimer’s and related neuropsychiatric disorders. They cover how Alzamend is trying to improve on current treatments by focusing on safer, more targeted approaches, including a next-generation lithium and an autologous immunotherapeutic vaccine. Alzamend Neuro Inc. https://www.biopharmcatalyst.com/com...

Who has been a guest on Biotech Bulls & Breakthroughs

Names identified in recent episode analyses. Showing up to five guests.

• Michael Heltzen
• Eric Duhaime
• Neil Lineberry
• Christopher Sheffield MD
• Billy Henry

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

YouTube views

63,282

Score snapshot 15 Sept 2025

Apple Podcasts (US)

4.5 / 5

2 ratings

Spotify

5.0 / 5

3 ratings

Podcast Authority Score: 46 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

44

Social presence

0

YouTube

85

Engagement

32

Contact Biotech Bulls & Breakthroughs

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Shows with a similar audience

• 

  Biotech Hangout

• 

  BioCentury This Week

• 

  The Long Run with Luke Timmerman

• 

  The Readout Loud

• 

  The Real Eisman Playbook

• 

  MarketBeat | Stock Market News & Analysis

Questions about Biotech Bulls & Breakthroughs